Citations

Citations to this article as recorded by  

• Lipocalin‐2—The myth of its expression and function
  Dahui Li, Wai Yan Sun, Bowen Fu, Aimin Xu, Yu Wang
  Basic & Clinical Pharmacology & Toxicology.2020; 127(2): 142.     CrossRef
• Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes
  Ioanna Mosialou, Steven Shikhel, Na Luo, Peristera Ioanna Petropoulou, Konstantinos Panitsas, Brygida Bisikirska, Nyanza J. Rothman, Roxane Tenta, Bertrand Cariou, Matthieu Wargny, Elisabeth Sornay-Rendu, Thomas Nickolas, Mishaela Rubin, Cyrille B. Confav
  Journal of Experimental Medicine.2020;[Epub]     CrossRef
• Metabolism and adult neurogenesis: Towards an understanding of the role of lipocalin-2 and iron-related oxidative stress
  Ana Catarina Ferreira, Nuno Sousa, João M. Bessa, João Carlos Sousa, Fernanda Marques
  Neuroscience & Biobehavioral Reviews.2018; 95: 73.     CrossRef
• LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
  Ziqi Dong, Hui Gong, Yadan Chen, Hong Wu, Jun Wu, Yinghong Deng, Xinmao Song
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue
  Prasad G. Kamble, Maria J. Pereira, Cherno O. Sidibeh, Sam Amini, Magnus Sundbom, Joey Lau Börjesson, Jan W. Eriksson
  Molecular and Cellular Endocrinology.2016; 427: 124.     CrossRef
• Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men
  Yuqi Luo, Xiaojing Ma, Xiaoping Pan, Yiting Xu, Qin Xiong, Yunfeng Xiao, Yuqian Bao, Weiping Jia
  Medicine.2016; 95(30): e4039.     CrossRef
• From the periphery to the brain: Lipocalin-2, a friend or foe?
  Ana C. Ferreira, Sandro Dá Mesquita, João C. Sousa, Margarida Correia-Neves, Nuno Sousa, Joana A. Palha, Fernanda Marques
  Progress in Neurobiology.2015; 131: 120.     CrossRef

Citations

Citations to this article as recorded by  

• Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease
  Guillaume Henin, Audrey Loumaye, Isabelle A. Leclercq, Nicolas Lanthier
  JHEP Reports.2024; 6(2): 100963.     CrossRef
• Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women
  Alexey A. Tinkov, Tatiana V. Korobeinikova, Galina D. Morozova, Michael Aschner, Daria V. Mak, Abel Santamaria, Joao B.T. Rocha, Tatiana I. Sotnikova, Serafima Ia. Tazina, Anatoly V. Skalny
  Journal of Trace Elements in Medicine and Biology.2024; 83: 127397.     CrossRef
• Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
  Dušan Mladenović, Milena Vesković, Nikola Šutulović, Dragan Hrnčić, Olivera Stanojlović, Lena Radić, Jelica Bjekić Macut, Djuro Macut
  Endocrine.2024;[Epub]     CrossRef
• Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
  Qiuyu Xu, Jie Zhang, Yan Lu, Ling Wu
  iScience.2024; 27(2): 108783.     CrossRef
• The role of hepatokines in NAFLD
  Norbert Stefan, Fritz Schick, Andreas L. Birkenfeld, Hans-Ulrich Häring, Morris F. White
  Cell Metabolism.2023; 35(2): 236.     CrossRef
• The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
  Li Qin, Junru Wu, Xuejing Sun, Xuewei Huang, Wei Huang, Chunyan Weng, Jingjing Cai
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise
  Ji Ye Lim, Eunju Kim
  Metabolites.2023; 13(9): 979.     CrossRef
• Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
  Aikaterini Giannouli, Charikleia Stefanaki, Christos Kouskoutis, Marianna Konidari, Iliana Mani, Konstantina Konidari, Sophia L. Markantonis, Aimilia Mantzou, Spyridon P. Dourakis, Efthymios Deligeoroglou, Flora Bacopoulou
  Journal of Clinical Medicine.2023; 12(17): 5744.     CrossRef
• The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
  Milena Vesković, Nikola Šutulović, Dragan Hrnčić, Olivera Stanojlović, Djuro Macut, Dušan Mladenović
  Current Issues in Molecular Biology.2023; 45(11): 9084.     CrossRef
• Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2
  Xinying Ye, Takashi Toyama, Keiko Taguchi, Kotoko Arisawa, Takayuki Kaneko, Ryouhei Tsutsumi, Masayuki Yamamoto, Yoshiro Saito
  Communications Biology.2023;[Epub]     CrossRef
• “Alphabet” Selenoproteins: Implications in Pathology
  Carmen Beatrice Dogaru, Carmen Duță, Corina Muscurel, Irina Stoian
  International Journal of Molecular Sciences.2023; 24(20): 15344.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease and the heart
  Stan Driessen, Sven M. Francque, Stefan D. Anker, Manuel Castro Cabezas, Diederick E. Grobbee, Maarten E. Tushuizen, Adriaan G. Holleboom
  Hepatology.2023;[Epub]     CrossRef
• Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
  Ruirui Yu, Zhoutian Wang, Miaomiao Ma, Ping Xu, Longjian Liu, Alexey A. Tinkov, Xin Gen Lei, Ji-Chang Zhou
  Antioxidants.2022; 11(7): 1263.     CrossRef
• Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
  Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman
  Journal of Cellular Biochemistry.2022; 123(10): 1553.     CrossRef
• Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
  Bing Yang, Liqing Lu, Dongmei Zhou, Wei Fan, Lucía Barbier-Torres, Justin Steggerda, Heping Yang, Xi Yang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Cytokines and regulation of glucose and lipid metabolism in the obesity
  V. I. Scherbakov, G. A. Skosyreva, T. I. Ryabichenko, O. O. Obukhova
  Obesity and metabolism.2022; 19(3): 317.     CrossRef
• SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway
  Yi Chen, Xinjue He, Xueyang Chen, Youming Li, Yini Ke
  Journal of Cellular Physiology.2021; 236(5): 3800.     CrossRef
• Hepatokines and metabolism: Deciphering communication from the liver
  Sharon O. Jensen-Cody, Matthew J. Potthoff
  Molecular Metabolism.2021; 44: 101138.     CrossRef
• Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD
  Sechang Oh, Takehiko Tsujimoto, Bokun Kim, Fumihiko Uchida, Hideo Suzuki, Seiichiro Iizumi, Tomonori Isobe, Takeji Sakae, Kiyoji Tanaka, Junichi Shoda
  JHEP Reports.2021; 3(3): 100253.     CrossRef
• Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
  Chance S. Friesen, Chelsea Hosey-Cojocari, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, Valentina Shakhnovich
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Association of Urinary and Dietary Selenium and of Serum Selenium Species with Serum Alanine Aminotransferase in a Healthy Italian Population
  Teresa Urbano, Tommaso Filippini, Daniela Lasagni, Tiziana De Luca, Peter Grill, Sabrina Sucato, Elisa Polledri, Guy Djeukeu Noumbi, Marcella Malavolti, Annalisa Santachiara, Thelma A. Pertinhez, Roberto Baricchi, Silvia Fustinoni, Bernhard Michalke, Marc
  Antioxidants.2021; 10(10): 1516.     CrossRef
• Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
  Kaitlin Day, Lucia A. Seale, Ross M. Graham, Barbara R. Cardoso
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
  Tae Hyun Kim, Dong-Gyun Hong, Yoon Mee Yang
  Biomedicines.2021; 9(12): 1903.     CrossRef
• Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis
  Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis, Hanna Bis-Wencel
  World Journal of Hepatology.2021; 13(12): 2071.     CrossRef
• Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men
  Scott A Willis, Jack A Sargeant, Thomas Yates, Toshinari Takamura, Hiroaki Takayama, Vinay Gupta, Emily Brittain, Joe Crawford, Siôn A Parry, Alice E Thackray, Veronica Varela-Mato, David J Stensel, Rachel M Woods, Carl J Hulston, Guruprasad P Aithal, Jam
  The Journal of Nutrition.2020; 150(5): 1076.     CrossRef
• Targeting fibrinogen‐like protein 1 is a novel therapeutic strategy to combat obesity
  Hung‐Tsung Wu, Szu‐Chi Chen, Kang‐Chih Fan, Chun‐Heng Kuo, Shin‐Yu Lin, Shu‐Huei Wang, Chih‐Jen Chang, Hung‐Yuan Li
  The FASEB Journal.2020; 34(2): 2958.     CrossRef
• Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
  Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina
  SAGE Open Medicine.2020; 8: 205031212093380.     CrossRef
• Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
  Anna Baran, Julia Nowowiejska, Julita Anna Krahel, Tomasz W. Kaminski, Magdalena Maciaszek, Iwona Flisiak
  International Journal of Molecular Sciences.2020; 21(13): 4594.     CrossRef
• The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
  Adrian M. Gonzalez-Gil, Leticia Elizondo-Montemayor
  Nutrients.2020; 12(6): 1899.     CrossRef
• Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More
  Ryouhei Tsutsumi, Yoshiro Saito
  Biological and Pharmaceutical Bulletin.2020; 43(3): 366.     CrossRef
• Selenium and selenoprotein P in nonalcoholic fatty liver disease
  Stergios A. Polyzos, Jannis Kountouras, Antonis Goulas, Leonidas Duntas
  Hormones.2020; 19(1): 61.     CrossRef
• The Effects of Endoplasmic-Reticulum-Resident Selenoproteins in a Nonalcoholic Fatty Liver Disease Pig Model Induced by a High-Fat Diet
  Pengzu Wang, Zhuang Lu, Meng He, Baoming Shi, Xingen Lei, Anshan Shan
  Nutrients.2020; 12(3): 692.     CrossRef
• The risk of pregnancy‐associated hypertension in women with nonalcoholic fatty liver disease
  Young Mi Jung, Seung Mi Lee, Subeen Hong, Ja Nam Koo, Ig Hwan Oh, Byoung Jae Kim, Sun Min Kim, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Sue Shin, Errol R. Norwitz, Chan‐Wook Park, Jong Kwan Jun, Won Kim, Joong Shin Park
  Liver International.2020; 40(10): 2417.     CrossRef
• Why Multiples of 21? Why does Selenoprotein P Contain Multiple Selenocysteine Residues?
  Janinah Baclaocos, John James Mackrill
  Current Nutraceuticals.2020; 1(1): 42.     CrossRef
• Selenium and Selenoproteins in Adipose Tissue Physiology and Obesity
  Alexey A. Tinkov, Olga P. Ajsuvakova, Tommaso Filippini, Ji-Chang Zhou, Xin Gen Lei, Eugenia R. Gatiatulina, Bernhard Michalke, Margarita G. Skalnaya, Marco Vinceti, Michael Aschner, Anatoly V. Skalny
  Biomolecules.2020; 10(4): 658.     CrossRef
• Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines
  Justine Faramia, Giada Ostinelli, Virginie Drolet-Labelle, Frédéric Picard, André Tchernof
  Current Opinion in Pharmacology.2020; 52: 67.     CrossRef
• Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
  David Carneros, Guillermo López-Lluch, Matilde Bustos
  Nutrients.2020; 12(11): 3472.     CrossRef
• Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
  Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Melania Gaggini, Fabrizia Carli, Maria Lorena Abate, Antonella Olivero, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Amalia Gastaldelli, Elisabetta Bugianesi
  International Journal of Molecular Sciences.2020; 21(22): 8838.     CrossRef
• Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
  Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Eugeniusz Tarasow, Malgorzata Wojtkowska, Dariusz Marek Lebensztejn
  Advances in Medical Sciences.2019; 64(2): 280.     CrossRef
• Dietary pattern associated with selenoprotein P and MRI-derived body fat volumes, liver signal intensity, and metabolic disorders
  Romina di Giuseppe, Sandra Plachta-Danielzik, Manja Koch, Ute Nöthlings, Sabrina Schlesinger, Jan Borggrefe, Marcus Both, Hans-Peter Müller, Jan Kassubek, Gunnar Jacobs, Wolfgang Lieb
  European Journal of Nutrition.2019; 58(3): 1067.     CrossRef
• Cytokines and Abnormal Glucose and Lipid Metabolism
  Jie Shi, Jiangao Fan, Qing Su, Zhen Yang
  Frontiers in Endocrinology.2019;[Epub]     CrossRef
• Role of exercise-induced hepatokines in metabolic disorders
  Gaël Ennequin, Pascal Sirvent, Martin Whitham
  American Journal of Physiology-Endocrinology and Metabolism.2019; 317(1): E11.     CrossRef
• Metabolomics signature associated with circulating serum selenoprotein P levels
  Romina di Giuseppe, Manja Koch, Ute Nöthlings, Gabi Kastenmüller, Anna Artati, Jerzy Adamski, Gunnar Jacobs, Wolfgang Lieb
  Endocrine.2019; 64(3): 486.     CrossRef
• Secretomics to Discover Regulators in Diseases
  Parkyong Song, Yonghoon Kwon, Jae-Yeol Joo, Do-Geun Kim, Jong Hyuk Yoon
  International Journal of Molecular Sciences.2019; 20(16): 3893.     CrossRef
• Impact of Lipotoxicity on Tissue “Cross Talk” and Metabolic Regulation
  Magdalene K. Montgomery, William De Nardo, Matthew J. Watt
  Physiology.2019; 34(2): 134.     CrossRef
• The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
  Matthew J Watt, Paula M Miotto, William De Nardo, Magdalene K Montgomery
  Endocrine Reviews.2019; 40(5): 1367.     CrossRef
• Inter-organ cross-talk in metabolic syndrome
  Christina Priest, Peter Tontonoz
  Nature Metabolism.2019; 1(12): 1177.     CrossRef
• Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population
  Swe Mar Oo, Hirofumi Misu, Yoshiro Saito, Mutsumi Tanaka, Seiji Kato, Yuki Kita, Hiroaki Takayama, Yumie Takeshita, Takehiro Kanamori, Toru Nagano, Masatoshi Nakagen, Takeshi Urabe, Naoto Matsuyama, Shuichi Kaneko, Toshinari Takamura
  Scientific Reports.2018;[Epub]     CrossRef
• NAFLD and cardiovascular disease
  Elisabete Martins, Ana Oliveira
  Porto Biomedical Journal.2018; 3(2): e2.     CrossRef
• The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men
  Jack A. Sargeant, Guruprasad P. Aithal, Toshinari Takamura, Hirofumi Misu, Hiroaki Takayama, Jessica A. Douglas, Mark C. Turner, David J. Stensel, Myra A. Nimmo, David R. Webb, Thomas Yates, James A. King
  Applied Physiology, Nutrition, and Metabolism.2018; 43(5): 482.     CrossRef
• Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study
  Teruki Miyake, Sakiko Yoshida, Shin Yamamoto, Shinya Furukawa, Osamu Yoshida, Sayaka Kanzaki, Hidenori Senba, Toru Ishihara, Mitsuhito Koizumi, Yoshio Tokumoto, Masashi Hirooka, Teru Kumagi, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura, Yoichi Hiasa
  Internal Medicine.2018; 57(19): 2799.     CrossRef
• Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation
  Ibrahim Cetindağlı, Muammer Kara, Alpaslan Tanoglu, Veysel Ozalper, Serkan Aribal, Yusuf Hancerli, Mehmet Unal, Onur Ozarı, Serdar Hira, Mustafa Kaplan, Yusuf Yazgan
  Clinics and Research in Hepatology and Gastroenterology.2017; 41(5): 516.     CrossRef
• Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels
  Teruki Miyake, Masashi Hirooka, Osamu Yoshida, Shinya Furukawa, Teru Kumagi, Mitsuhito Koizumi, Shin Yamamoto, Taira Kuroda, Eiji Arimitsu, Eiji Takeshita, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura, Yoichi Hiasa
  Journal of Gastroenterology.2017; 52(2): 237.     CrossRef
• Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
  Ruth C. R. Meex, Matthew J. Watt
  Nature Reviews Endocrinology.2017; 13(9): 509.     CrossRef
• Circulating selenoprotein P levels in relation to MRI‐derived body fat volumes, liver fat content, and metabolic disorders
  Romina di Giuseppe, Manja Koch, Sabrina Schlesinger, Jan Borggrefe, Marcus Both, Hans‐Peter Müller, Jan Kassubek, Gunnar Jacobs, Ute Nöthlings, Wolfgang Lieb
  Obesity.2017; 25(6): 1128.     CrossRef
• Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes
  Natsumi Tajima-Shirasaki, Kiyo-aki Ishii, Hiroaki Takayama, Takayoshi Shirasaki, Hisakazu Iwama, Keita Chikamoto, Yoshiro Saito, Yasumasa Iwasaki, Atsushi Teraguchi, Fei Lan, Akihiro Kikuchi, Yumie Takeshita, Koji Murao, Seiichi Matsugo, Shuichi Kaneko, H
  Journal of Biological Chemistry.2017; 292(26): 10791.     CrossRef
• Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance
  Miaoxin Chen, Bo Liu, David Wilkinson, Amy T. Hutchison, Campbell H. Thompson, Gary A. Wittert, Leonie K. Heilbronn
  Obesity Research & Clinical Practice.2017; 11(2): 227.     CrossRef
• Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
  Hak Soo Kim, Yong Kyun Cho
  The Korean Journal of Gastroenterology.2017; 69(6): 333.     CrossRef
• Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies
  Yong-ho Lee, Sang-Guk Lee, Chan Joo Lee, Soo Hyun Kim, Young-Mi Song, Mi Ra Yoon, Byung Hun Jeon, Jae Hyuk Lee, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong-Soo Cha
  Scientific Reports.2016;[Epub]     CrossRef
• Implication of hepatokines in metabolic disorders and cardiovascular diseases
  Tae Woo Jung, Hye Jin Yoo, Kyung Mook Choi
  BBA Clinical.2016; 5: 108.     CrossRef
• Selenoproteins: Antioxidant selenoenzymes and beyond
  Holger Steinbrenner, Bodo Speckmann, Lars-Oliver Klotz
  Archives of Biochemistry and Biophysics.2016; 595: 113.     CrossRef
• Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines
  Kyoung-Jin Oh, Da Lee, Won Kim, Baek Han, Sang Lee, Kwang-Hee Bae
  International Journal of Molecular Sciences.2016; 18(1): 8.     CrossRef
• Pathogenesis of nonalcoholic steatohepatitis
  Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker
  Cellular and Molecular Life Sciences.2016; 73(10): 1969.     CrossRef
• Stéatose et résistance à l’insuline : implication des hépatokines
  C. Bertrand, P. Valet, I. Castan-Laurell
  Obésité.2016; 11(3): 170.     CrossRef
• Pathophysiology of Non Alcoholic Fatty Liver Disease
  Salvatore Petta, Amalia Gastaldelli, Eleni Rebelos, Elisabetta Bugianesi, Piergiorgio Messa, Luca Miele, Gianluca Svegliati-Baroni, Luca Valenti, Ferruccio Bonino
  International Journal of Molecular Sciences.2016; 17(12): 2082.     CrossRef
• Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study
  Sahar A. Ali, Walaa M.H. Nassif, Dalia H.A. Abdelaziz
  Clinics and Research in Hepatology and Gastroenterology.2016; 40(4): 465.     CrossRef
• Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
  Sven M. Francque, Denise van der Graaff, Wilhelmus J. Kwanten
  Journal of Hepatology.2016; 65(2): 425.     CrossRef
• “Omics” of Selenium Biology: A Prospective Study of Plasma Proteome Network Before and After Selenized-Yeast Supplementation in Healthy Men
  Indu Sinha, Kubra Karagoz, Rachel L. Fogle, Christopher S. Hollenbeak, Arnold H. Zea, Kazim Y. Arga, Anne E. Stanley, Wayne C. Hawkes, Raghu Sinha
  OMICS: A Journal of Integrative Biology.2016; 20(4): 202.     CrossRef
• Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation
  Sandra Carias, Ana Lia Castellanos, Valery Vilchez, Rashmi Nair, Anna Christina Dela Cruz, Jennifer Watkins, Terrence Barrett, Patel Trushar, Karyn Esser, Roberto Gedaly
  Journal of Gastroenterology and Hepatology.2016; 31(3): 628.     CrossRef
• Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes
  Sofiya Gancheva, Alessandra Bierwagen, Kirti Kaul, Christian Herder, Peter Nowotny, Sabine Kahl, Guido Giani, Birgit Klueppelholz, Birgit Knebel, Paul Begovatz, Klaus Strassburger, Hadi Al-Hasani, Jesper Lundbom, Julia Szendroedi, Michael Roden
  Diabetes.2016; 65(7): 1849.     CrossRef
• Selenoprotein P is not elevated in gestational diabetes mellitus
  Alev E. Altinova, Ozlem T. Iyidir, Cigdem Ozkan, Damla Ors, Merve Ozturk, Ozlem Gulbahar, Nuray Bozkurt, Fusun B. Toruner, Mujde Akturk, Nuri Cakir, Metin Arslan
  Gynecological Endocrinology.2015; 31(11): 874.     CrossRef
• Selenium and Human Health: Witnessing a Copernican Revolution?
  Ewa Jablonska, Marco Vinceti
  Journal of Environmental Science and Health, Part C.2015; 33(3): 328.     CrossRef
• Toenail selenium and risk of type 2 diabetes: the ORDET cohort study
  Marco Vinceti, Sara Grioni, Dorothea Alber, Dario Consonni, Carlotta Malagoli, Claudia Agnoli, Marcella Malavolti, Valeria Pala, Vittorio Krogh, Sabina Sieri
  Journal of Trace Elements in Medicine and Biology.2015; 29: 145.     CrossRef
• Expression of Selenoprotein Genes Is Affected by Obesity of Pigs Fed a High-Fat Diet
  Hua Zhao, Ke Li, Jia-Yong Tang, Ji-Chang Zhou, Kang-Ning Wang, Xin-Jie Xia, Xin Gen Lei
  The Journal of Nutrition.2015; 145(7): 1394.     CrossRef
• Hepatokines as a Link between Obesity and Cardiovascular Diseases
  Hye Jin Yoo, Kyung Mook Choi
  Diabetes & Metabolism Journal.2015; 39(1): 10.     CrossRef
• The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
  Takayasu Ideta, Yohei Shirakami, Tsuneyuki Miyazaki, Takahiro Kochi, Hiroyasu Sakai, Hisataka Moriwaki, Masahito Shimizu
  International Journal of Molecular Sciences.2015; 16(12): 29207.     CrossRef
• Dietary selenate attenuates adiposity and improves insulin sensitivity in high-fat diet-induced obese mice
  Choon Young Kim, Yuyan Zhu, Kimberly K. Buhman, Kee-Hong Kim
  Journal of Functional Foods.2015; 17: 33.     CrossRef
• Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
  Gyuri Kim, Yong-ho Lee, Young Min Park, Jungghi Kim, Heesuk Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Dae Jung Kim
  Medicine.2015; 94(27): e1103.     CrossRef
• Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells
  Sattar Gorgani-Firuzjaee, Khosrow Adeli, Reza Meshkani
  Biochemical and Biophysical Research Communications.2015; 464(2): 441.     CrossRef
• Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A via Improvement of Palmitic Acid-Induced Endoplasmic Reticulum Stress by AMPK
  Jinmi Lee, Seok-Woo Hong, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
  Endocrinology and Metabolism.2015; 30(2): 177.     CrossRef
• AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes
  Tae Woo Jung, So Young Lee, Ho Cheol Hong, Hae Yoon Choi, Hye Jin Yoo, Sei Hyun Baik, Kyung Mook Choi
  Molecular and Cellular Endocrinology.2014; 382(1): 66.     CrossRef
• HIF‐1α Expression as a Protective Strategy of HepG2 Cells Against Fatty Acid‐Induced Toxicity
  Wonbaek Yoo, Kyung Hee Noh, Jae Hee Ahn, Ji Hee Yu, Ji A. Seo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Tae Woo Kim, Hyo Joon Kim, Nan Hee Kim
  Journal of Cellular Biochemistry.2014; 115(6): 1147.     CrossRef
• Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics
  Jacklyn N. Hellwege, Nicholette D. Palmer, Julie T. Ziegler, Carl D. Langefeld, Carlos Lorenzo, Jill M. Norris, Toshinari Takamura, Donald W. Bowden
  Gene.2014; 534(1): 33.     CrossRef
• Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children
  B-J Ko, S M Kim, K H Park, H S Park, C S Mantzoros
  International Journal of Obesity.2014; 38(12): 1497.     CrossRef
• The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels
  Kyung-Soo Kim, Hyun-Ju Oh, Dae-Jung Kim, Soo-Kyung Kim, Seok Won Park, Yong-Wook Cho, Kap-Bum Huh
  Endocrine Journal.2013; 60(12): 1295.     CrossRef

Citations

Citations to this article as recorded by  

• Up-Date on Diabetic Nephropathy
  Maria Chiara Pelle, Michele Provenzano, Marco Busutti, Clara Valentina Porcu, Isabella Zaffina, Lucia Stanga, Franco Arturi
  Life.2022; 12(8): 1202.     CrossRef
• The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
  A. Yu. Zharikov, S. O. Filinova, O. N. Mazko, O. G. Makarova, I. P. Bobrov, V. M. Bryukhanov
  Bulletin of Siberian Medicine.2021; 20(2): 29.     CrossRef
• Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
  Johannes J. Kovarik, Christopher C. Kaltenecker, Oliver Domenig, Marlies Antlanger, Marko Poglitsch, Chantal Kopecky, Marcus D. Säemann
  Diabetes Therapy.2021; 12(9): 2485.     CrossRef
• Diabetic nephropathy: An update on pathogenesis and drug development
  Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754.     CrossRef
• Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
  Li‐Jing Sun, Yan‐Ni Sun, Jian‐Ping Shan, Geng‐Ru Jiang
  Journal of Diabetes Investigation.2017; 8(4): 609.     CrossRef
• New agents modulating the renin-angiotensin-aldosterone system—Will there be a new therapeutic option?
  Anna Gromotowicz-Poplawska, Piotr Szoka, Patrycjusz Kolodziejczyk, Karol Kramkowski, Marzena Wojewodzka-Zelezniakowicz, Ewa Chabielska
  Experimental Biology and Medicine.2016; 241(17): 1888.     CrossRef
• Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell
  Jing Xiao, Weijun Chen, Yijun Lu, Xiaoli Zhang, Chensheng Fu, Zhenwen Yan, Zhenxing Zhang, Zhibin Ye
  Inflammation Research.2015; 64(8): 603.     CrossRef
• Eplerenone reduces arterial thrombosis in diabetic rats
  Agnieszka Zakrzeska, Anna Gromotowicz-Popławska, Janusz Szemraj, Piotr Szoka, Wioleta Kisiel, Tomasz Purta, Irena Kasacka, Ewa Chabielska
  Journal of the Renin-Angiotensin-Aldosterone System.2015; 16(4): 1085.     CrossRef
• Pharmacological modulation of fibrinolytic response – In vivo and in vitro studies
  Karol Kramkowski, Agnieszka Leszczynska, Wlodzimierz Buczko
  Pharmacological Reports.2015; 67(4): 695.     CrossRef